4.5 Article

H-Ras Distribution and Signaling in Plasma Membrane Microdomains Are Regulated by Acylation and Deacylation Events

期刊

MOLECULAR AND CELLULAR BIOLOGY
卷 35, 期 11, 页码 1898-1914

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/MCB.01398-14

关键词

-

资金

  1. Spanish Ministry of Economy-Fondos FEDER [BFU2011-23807]
  2. Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Spanish Ministry of Health [RD/12/0036/0033]
  3. European Research Council [ERC-AG/250297-RAS AHEAD]
  4. Spanish Ministry of Science and Innovation [SAF2006-11773, CSD2007-00017]

向作者/读者索取更多资源

H-Ras must adhere to the plasma membrane to be functional. This is accomplished by posttranslational modifications, including palmitoylation, a reversible process whereby H-Ras traffics between the plasma membrane and the Golgi complex. At the plasma membrane, H-Ras has been proposed to occupy distinct sublocations, depending on its activation status: lipid rafts/detergent-resistant membrane fractions when bound to GDP, diffusing to disordered membrane/soluble fractions in response to GTP loading. Herein, we demonstrate that H-Ras sublocalization is dictated by its degree of palmitoylation in a cell type-specific manner. Whereas H-Ras localizes to detergent-resistant membrane fractions in cells with low palmitoylation activity, it locates to soluble membrane fractions in lineages where it is highly palmitoylated. Interestingly, in both cases GTP loading results in H-Ras diffusing away from its original sublocalization. Moreover, tilting the equilibrium between palmitoylation and depalmitoylation processes can substantially alter H-Ras segregation and, subsequently, its biochemical and biological functions. Thus, the palmitoylation/depalmitoylation balance not only regulates H-Ras cycling between endomembranes and the plasma membrane but also serves as a key orchestrator of H-Ras lateral diffusion between different types of plasma membrane and thereby of H-Ras signaling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Novel roles of PRK1 and PRK2 in cilia and cancer biology

Hitesh Patel, Jun Li, Ana Herrero, Jakob Kroboth, Adam Byron, Alex Von Kriegsheim, Valerie Brunton, Neil Carragher, Toby Hurd, Margaret Frame

SCIENTIFIC REPORTS (2020)

Article Cell Biology

RAC1 induces nuclear alterations through the LINC complex to enhance melanoma invasiveness

Paula Colon-Bolea, Rocio Garcia-Gomez, Sue Shackleton, Piero Crespo, Xose R. Bustelo, Berta Casar

MOLECULAR BIOLOGY OF THE CELL (2020)

Article Oncology

RAS Subcellular Localization Inversely Regulates Thyroid Tumor Growth and Dissemination

Yaiza Garcia-Ibanez, Garcilaso Riesco-Eizaguirre, Pilar Santisteban, Berta Casar, Piero Crespo

CANCERS (2020)

Editorial Material Biochemistry & Molecular Biology

Editorial overview: Macromolecular assemblies: clues from structural insights

Kylie J. Walters, Piero Crespo

CURRENT OPINION IN STRUCTURAL BIOLOGY (2021)

Article Multidisciplinary Sciences

Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma

Miguel Angel Merlos Rodrigo, Hana Michalkova, Vladislav Strmiska, Berta Casar, Piero Crespo, Vivian de los Rios, J. Ignacio Casal, Yazan Haddad, Roman Guran, Tomas Eckschlager, Petra Pokorna, Zbynek Heger, Vojtech Adam

Summary: This study revealed that up-regulation of metallothionein-3 (hMT3) in neuroblastoma cells was associated with increased cisplatin resistance, indicating a potential cause for tumor relapse. Multiple biological pathways related to apoptosis, transport, proteasome, and cellular stress were implicated in cisplatin resistance in hMT3-overexpressing neuroblastoma cells.

SCIENTIFIC REPORTS (2021)

Article Biochemistry & Molecular Biology

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer

Thaidy Moreno, Beatriz Monterde, Laura Gonzalez-Silva, Isabel Betancor-Fernandez, Carlos Revilla, Antonio Agraz-Doblas, Javier Freire, Pablo Isidro, Laura Quevedo, Rosa Blanco, Santiago Montes-Moreno, Laura Cereceda, Aurora Astudillo, Berta Casar, Piero Crespo, Cristina Morales Torres, Paola Scaffidi, Javier Gomez-Roman, Eduardo Salido, Ignacio Varela

Summary: This study found that 20% of lung cancer patients exhibit ARID2 protein loss, which leads to chromatin structural changes, enhanced cell proliferation and metastasis, and impaired DNA repair, increasing sensitivity to DNA-damaging agents. These findings suggest that ARID2 is a potential tumor suppressor gene and therapeutic target in lung cancer.

ONCOGENE (2021)

Review Genetics & Heredity

RAS Dimers: The Novice Couple at the RAS-ERK Pathway Ball

Ana Herrero, Piero Crespo

Summary: Signals transmitted through the RAS-ERK pathway play a crucial role in cancer-related cellular processes. RAS dimerization, especially at membrane microdomains, is essential for RAF activation and can be targeted pharmacologically to prevent tumorigenesis.
Article Biochemistry & Molecular Biology

The Rho guanosine nucleotide exchange factors Vav2 and Vav3 modulate epidermal stem cell function

L. Francisco Lorenzo-Martin, Mauricio Menacho-Marquez, Natalia Fernandez-Parejo, Sonia Rodriguez-Fdez, Gloria Pascual, Antonio Abad, Piero Crespo, Mercedes Dosil, Salvador A. Benitah, Xose R. Bustelo

Summary: Research shows that Rho GTPases control different aspects of skin stem cells, and their upstream regulators Vav2 and Vav3 affect the number, functional status, and responsiveness of hair follicle bulge stem cells under normal and tumorigenic conditions. These findings highlight the role of these regulators in normal and tumor epidermal stem cells.

ONCOGENE (2022)

Article Multidisciplinary Sciences

Characterisation of a nucleo-adhesome

Adam Byron, Billie G. C. Griffith, Ana Herrero, Alexander E. P. Loftus, Emma S. Koeleman, Linda Kogerman, John C. Dawson, Niamh McGivern, Jayne Culley, Graeme R. Grimes, Bryan Serrels, Alex von Kriegsheim, Valerie G. Brunton, Margaret C. Frame

Summary: This study reports the localization of cell adhesion proteins in the nucleus and establishes a nucleo-adhesome, demonstrating their role in transcriptional control. It provides experimental evidence for the cooperation of nuclear adhesion proteins in regulating gene expression.

NATURE COMMUNICATIONS (2022)

Review Biochemistry & Molecular Biology

Immune Checkpoint Inhibitors and RAS-ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma

Marta Morante, Atanasio Pandiella, Piero Crespo, Ana Herrero

Summary: Metastatic melanoma is an immunogenic tumor with poor survival rates, being targeted by immune checkpoint inhibitors. Despite improvements in overall survival rates, melanoma cells develop resistance mechanisms. The combination of RAS-ERK pathway inhibitors and ICI therapy shows promising advantages for treatment.

BIOMOLECULES (2022)

Article Multidisciplinary Sciences

Scaffold coupling: ERK activation by trans- phosphorylation across different scaffold protein species

Ana Martin-Vega, Laura Ruiz-Peinado, Rocio Garcia-Gomez, Ana Herrero, Dalia de la Fuente-Vivas, Swetha Parvathaneni, Ruben Caloto, Marta Morante, Alex von Kriegsheim, Xose R. Bustelo, David B. Sacks, Berta Casar, Piero Crespo

Summary: RAS-ERK pathway signals are regulated by scaffold proteins, and it is revealed that scaffold proteins can interact with each other and undergo phosphorylation reactions. The trans-phosphorylation process participates in KSR1-regulated adipogenesis and the cytotoxicity exhibited by KSR-directed inhibitors. This finding has implications in signaling and the design of scaffold protein-aimed therapeutics.

SCIENCE ADVANCES (2023)

Article Biochemistry & Molecular Biology

ERK2 stimulates MYC transcription by anchoring CDK9 to the MYC promoter in a kinase activity-independent manner

Lorena Agudo-Ibanez, Marta Morante, Lucia Garcia-Gutierrez, Andrea Quintanilla, Javier Rodriguez, Alberto Munoz, Javier Leon, Piero Crespo

Summary: The transcription factor MYC is regulated by the kinase activity of ERK2 and plays a role in cell proliferation, transformation, and survival. ERK2 was found to directly regulate MYC transcription by binding to the MYC promoter. ERK2 increased MYC expression and protein abundance in the nucleus, independent of its kinase activity, through interactions with CDK9. These findings demonstrate a kinase-independent role for ERK2 in promoting MYC expression by anchoring CDK9 to the MYC promoter.

SCIENCE SIGNALING (2023)

暂无数据